ferric maltol has been researched along with Colitis Gravis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Akobeng, AK; Allen, P; Engineer, J; Gordon, M; Hoque, S; Iheozor-Ejiofor, Z; Iqbal, T; Sinopoulou, V | 1 |
| Ahmad, T; Baumgart, DC; Bokemeyer, B; Büning, C; Gasche, C; Howaldt, S; Stallmach, A; Tulassay, Z | 1 |
| Ahmad, T; Baumgart, DC; Bokemeyer, B; Büning, C; Howaldt, S; Schmidt, C; Stallmach, A; Tulassay, Z | 1 |
1 review(s) available for ferric maltol and Colitis Gravis
| Article | Year |
|---|---|
Interventions for treating iron deficiency anaemia in inflammatory bowel disease.
Topics: Adolescent; Adult; Aged; Anemia, Iron-Deficiency; Bias; Colitis, Ulcerative; Crohn Disease; Disaccharides; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Fumarates; Hematinics; Humans; Iron Compounds; Maltose; Middle Aged; Placebos; Pyrones; Randomized Controlled Trials as Topic; Young Adult | 2021 |
2 trial(s) available for ferric maltol and Colitis Gravis
| Article | Year |
|---|---|
Ferric maltol is effective in correcting iron deficiency anemia in patients with inflammatory bowel disease: results from a phase-3 clinical trial program.
Topics: Administration, Oral; Adult; Anemia, Iron-Deficiency; Colitis, Ulcerative; Crohn Disease; Double-Blind Method; Female; Ferric Compounds; Hemoglobins; Humans; Male; Maximum Tolerated Dose; Prognosis; Pyrones; Quality of Life | 2015 |
Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: long-term extension data from a Phase 3 study.
Topics: Administration, Oral; Adult; Aged; Anemia, Iron-Deficiency; Colitis, Ulcerative; Crohn Disease; Double-Blind Method; Female; Ferric Compounds; Hemoglobins, Abnormal; Humans; Inflammatory Bowel Diseases; Iron; Male; Middle Aged; Pyrones | 2016 |